Preeclampsia (PE) is a multisystem obstetric disorder that affects 2-10% of pregnancies worldwide and it is a leading cause of maternal and fetal morbidity and mortality. The etiology of PE development is not clearly delineated, but since delivery of the fetus and placenta often leads to symptom resolution in the most cases of PE, it is hypothesized that the placenta is the inciting factor of the disease. Current management strategies for PE focus on treating the maternal symptoms to stabilize the mother in an attempt to prolong the pregnancy. However, the efficacy of this management strategy is limited. Therefore, identification of novel therapeutic targets and strategies is needed. Here, we provide a comprehensive overview of the current state of knowledge regarding mechanisms of vascular and renal pathophysiology during PE and discuss potential therapeutic targets directed at improving maternal vascular and renal function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062189PMC
http://dx.doi.org/10.1016/j.cophys.2023.100655DOI Listing

Publication Analysis

Top Keywords

vascular renal
12
therapeutic targets
8
renal mechanisms
4
mechanisms preeclampsia
4
preeclampsia preeclampsia
4
preeclampsia multisystem
4
multisystem obstetric
4
obstetric disorder
4
disorder 2-10%
4
2-10% pregnancies
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!